Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Small Intestinal Ketogenesis - Potential Significance for Type 2 Diabetes in Obesity

NCT05767177 is registered in ClinicalTrials.gov with Göteborg University as lead sponsor.

NCT NCT05767177
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05767177 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Small Intestinal Ketogenesis - Potential Significance for Type 2 Diabetes in Obesity
Lead sponsor
Göteborg University
Phase
Not applicable
Overall status
Completed
Start date
June 1, 2023
Completion date
April 22, 2025
Enrollment
12 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

diabetes mellitus, type 2, incretins, intestines, obesity, morbid